StonvexLoading…
StonvexStonvexStonvexCore line items from PACS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-06-30 | Annual 2024 2024-03-31 |
|---|---|---|---|---|
Revenue | $5.29B | $4.09B | $1.85B | $919.41M |
Operating Income | $309.60M | $123.07M | $28.13M | $65.31M |
Net Income | $191.54M | $55.76M | $2.94M | $34.82M |
EPS (Diluted) | $1.22 | $0.38 | $0.02 | $0.27 |
Total Assets | $5.58B | $5.24B | $3.93B | $3.86B |
Total Liabilities | $4.63B | $4.53B | $3.39B | $3.74B |
Cash & Equivalents | $197.02M | $157.67M | $73.37M | $81.21M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 156.62M | 155.18M | 152.40M | 128.72M |